INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS"

GENEVA, Oct. 6 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/021444) for "CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS" on Mar 26, 2025. With publication no. WO/2025/207705, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BELKMONTES, Brian (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), SLEMMONS, Katherine (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), EGGERT, Tobias (c/o Amg...